Abstract

Review Article

Renal neoplasms and computed tomography

Hajra Idrees, MBBS*, Raza Zarrar, MBBS, Bilal Mujtaba and MD

Published: 08 November, 2022 | Volume 6 - Issue 3 | Pages: 022-026

Introduction: In recent years the increased utilization of imaging modalities has led to an accelerated diagnosis of renal masses. Initial diagnoses and staging are commonly done with the abdominal Computed Tomography (CT). This study evaluates the various aspects to consider when utilizing CT scan for the diagnosis of renal masses.
Discussion: CT scan is the most important imaging modality to evaluate renal neoplasms. Postcontrast acquisitions can be tailored according to the indication for the study. This alongside various techniques, imaging modalities and classification systems may help differentiate the malignant Renal Cell Carcinoma, from benign or metastatic lesions, lymphomas or renal pseudotumor. Finally CT can also be utilized alongside other tools for staging the tumor. 
Conclusion: Certain CT imaging features are pertinent to evaluate the malignancy potential of renal lesions. However the CT alone may be inconclusive in diagnosing the majority of renal neoplasms, excluding AML with macroscopic fat. Hence it is recommended that the CT aid additional imaging modalities and tools to reach an accurate diagnosis.

Read Full Article HTML DOI: 10.29328/journal.jro.1001043 Cite this Article Read Full Article PDF

References

  1. Wang ZJ, Westphalen AC, Zagoria RJ. CT and MRI of small renal masses. Br J Radiol. 2018 Jul;91(1087):20180131. doi: 10.1259/bjr.20180131. Epub 2018 May 10. PMID: 29668296; PMCID: PMC6221773.
  2. Gray RE, Harris GT. Renal Cell Carcinoma: Diagnosis and Management. Am Fam Physician. 2019 Feb 1;99(3):179-184. Erratum in: Am Fam Physician. 2019 Jun 15;99(12):732. PMID: 30702258.
  3. Diagnostic approach, differential diagnosis, and management of a small renal mass. https://www.uptodate.com/contents/diagnostic-approach-differential-diagnosis-and-management-of-a-small-renal-mass?search=RENAL%20MASSES%20TYPES&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1
  4. Campbell S, Uzzo RG, Allaf ME, Bass EB, Cadeddu JA, Chang A, Clark PE, Davis BJ, Derweesh IH, Giambarresi L, Gervais DA, Hu SL, Lane BR, Leibovich BC, Pierorazio PM. Renal Mass and Localized Renal Cancer: AUA Guideline. J Urol. 2017 Sep;198(3):520-529. doi: 10.1016/j.juro.2017.04.100. Epub 2017 May 4. PMID: 28479239.
  5. Kang SK, Kim D, Chandarana H. Contemporary imaging of the renal mass. Curr Urol Rep. 2011 Feb;12(1):11-7. doi: 10.1007/s11934-010-0148-y. PMID: 20949339.
  6. Comai A, Trenti M, Mayr R, Pycha A, Bonatti G, Lodde M. Computed tomography after nephron-sparing surgery. Abdom Imaging. 2015 Oct;40(7):2424-31. doi: 10.1007/s00261-015-0410-3. PMID: 25820803.
  7. Kutanzi KR, Lumen A, Koturbash I, Miousse IR. Pediatric Exposures to Ionizing Radiation: Carcinogenic Considerations. Int J Environ Res Public Health. 2016 Oct 28;13(11):1057. doi: 10.3390/ijerph13111057. PMID: 27801855; PMCID: PMC5129267.
  8. Andreucci M, Solomon R, Tasanarong A. Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention. Biomed Res Int. 2014;2014:741018. doi: 10.1155/2014/741018. Epub 2014 May 11. PMID: 24895606; PMCID: PMC4034507.
  9. Rossi SH, Klatte T, Usher-Smith J, Stewart GD. Epidemiology and screening for renal cancer. World J Urol. 2018 Sep;36(9):1341-1353. doi: 10.1007/s00345-018-2286-7. Epub 2018 Apr 2. PMID: 29610964; PMCID: PMC6105141.
  10. Pierorazio PM, Patel HD, Johnson MH, Sozio SM, Sharma R, Iyoha E, Bass EB, Allaf ME. Distinguishing malignant and benign renal masses with composite models and nomograms: A systematic review and meta-analysis of clinically localized renal masses suspicious for malignancy. Cancer. 2016 Nov 15;122(21):3267-3276. doi: 10.1002/cncr.30268. Epub 2016 Aug 10. PMID: 27508947.
  11. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003 Dec;170(6 Pt 1):2217-20. doi: 10.1097/01.ju.0000095475.12515.5e. PMID: 14634382.
  12. Srigley JR, Delahunt B, Eble JN, Egevad L, Epstein JI, Grignon D, Hes O, Moch H, Montironi R, Tickoo SK, Zhou M, Argani P; ISUP Renal Tumor Panel. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol. 2013 Oct;37(10):1469-89. doi: 10.1097/PAS.0b013e318299f2d1. PMID: 24025519.
  13. Thompson RH, Hill JR, Babayev Y, Cronin A, Kaag M, Kundu S, Bernstein M, Coleman J, Dalbagni G, Touijer K, Russo P. Metastatic renal cell carcinoma risk according to tumor size. J Urol. 2009 Jul;182(1):41-5. doi: 10.1016/j.juro.2009.02.128. Epub 2009 May 17. PMID: 19450840; PMCID: PMC2735023.
  14. Jewett MA, Mattar K, Basiuk J, Morash CG, Pautler SE, Siemens DR, Tanguay S, Rendon RA, Gleave ME, Drachenberg DE, Chow R, Chung H, Chin JL, Fleshner NE, Evans AJ, Gallie BL, Haider MA, Kachura JR, Kurban G, Fernandes K, Finelli A. Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol. 2011 Jul;60(1):39-44. doi: 10.1016/j.eururo.2011.03.030. Epub 2011 Apr 1. PMID: 21477920.
  15. Pierorazio PM, Johnson MH, Ball MW, Gorin MA, Trock BJ, Chang P, Wagner AA, McKiernan JM, Allaf ME. Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry. Eur Urol. 2015 Sep;68(3):408-15. doi: 10.1016/j.eururo.2015.02.001. Epub 2015 Feb 16. PMID: 25698065.
  16. Thompson RH, Kurta JM, Kaag M, Tickoo SK, Kundu S, Katz D, Nogueira L, Reuter VE, Russo P. Tumor size is associated with malignant potential in renal cell carcinoma cases. J Urol. 2009 May;181(5):2033-6. doi: 10.1016/j.juro.2009.01.027. Epub 2009 Mar 14. PMID: 19286217; PMCID: PMC2734327.
  17. Perez-Ordonez B, Hamed G, Campbell S, Erlandson RA, Russo P, Gaudin PB, Reuter VE. Renal oncocytoma: a clinicopathologic study of 70 cases. Am J Surg Pathol. 1997 Aug;21(8):871-83. doi: 10.1097/00000478-199708000-00001. PMID: 9255250.
  18. Lane BR, Aydin H, Danforth TL, Zhou M, Remer EM, Novick AC, Campbell SC. Clinical correlates of renal angiomyolipoma subtypes in 209 patients: classic, fat poor, tuberous sclerosis associated and epithelioid. J Urol. 2008 Sep;180(3):836-43. doi: 10.1016/j.juro.2008.05.041. Epub 2008 Jul 16. PMID: 18635231.
  19. Kim JK, Park SY, Shon JH, Cho KS. Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT. Radiology. 2004 Mar;230(3):677-84. doi: 10.1148/radiol.2303030003. PMID: 14990834.
  20. Bhatt JR, Richard PO, Kim NS, Finelli A, Manickavachagam K, Legere L, Evans A, Pei Y, Sykes J, Jhaveri K, Jewett MAS. Natural History of Renal Angiomyolipoma (AML): Most Patients with Large AMLs >4cm Can Be Offered Active Surveillance as an Initial Management Strategy. Eur Urol. 2016 Jul;70(1):85-90. doi: 10.1016/j.eururo.2016.01.048. Epub 2016 Feb 9. PMID: 26873836.
  21. Yan J, Cheng JL, Li CF, Lian YB, Zheng Y, Zhang XP, Wang CY. The findings of CT and MRI in patients with metanephric adenoma. Diagn Pathol. 2016 Oct 27;11(1):104. doi: 10.1186/s13000-016-0535-x. PMID: 27784295; PMCID: PMC5081663.
  22. Davis CJ Jr, Barton JH, Sesterhenn IA, Mostofi FK. Metanephric adenoma. Clinicopathological study of fifty patients. Am J Surg Pathol. 1995 Oct;19(10):1101-14. doi: 10.1097/00000478-199510000-00001. PMID: 7573669.
  23. Patel U, Ramachandran N, Halls J, Parthipun A, Slide C. Synchronous renal masses in patients with a nonrenal malignancy: incidence of metastasis to the kidney versus primary renal neoplasia and differentiating features on CT. AJR Am J Roentgenol. 2011 Oct;197(4):W680-6. doi: 10.2214/AJR.11.6518. PMID: 21940540.
  24. Luciano RL, Brewster UC. Kidney involvement in leukemia and lymphoma. Adv Chronic Kidney Dis. 2014 Jan;21(1):27-35. doi: 10.1053/j.ackd.2013.07.004. PMID: 24359984.
  25. Park BK. Renal Angiomyolipoma: Radiologic Classification and Imaging Features According to the Amount of Fat. AJR Am J Roentgenol. 2017 Oct;209(4):826-835. doi: 10.2214/AJR.17.17973. Epub 2017 Jul 20. PMID: 28726505.
  26. Berland LL, Silverman SG, Gore RM, Mayo-Smith WW, Megibow AJ, Yee J, Brink JA, Baker ME, Federle MP, Foley WD, Francis IR, Herts BR, Israel GM, Krinsky G, Platt JF, Shuman WP, Taylor AJ. Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol. 2010 Oct;7(10):754-73. doi: 10.1016/j.jacr.2010.06.013. PMID: 20889105.
  27. Newatia A, Khatri G, Friedman B, Hines J. Subtraction imaging: applications for nonvascular abdominal MRI. AJR Am J Roentgenol. 2007 Apr;188(4):1018-25. doi: 10.2214/AJR.05.2182. PMID: 17377038.
  28. Silverman SG, Pedrosa I, Ellis JH, Hindman NM, Schieda N, Smith AD, Remer EM, Shinagare AB, Curci NE, Raman SS, Wells SA, Kaffenberger SD, Wang ZJ, Chandarana H, Davenport MS. Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment. Radiology. 2019 Aug;292(2):475-488. doi: 10.1148/radiol.2019182646. Epub 2019 Jun 18. PMID: 31210616; PMCID: PMC6677285.
  29. Israel GM, Bosniak MA. An update of the Bosniak renal cyst classification system. Urology. 2005 Sep;66(3):484-8. doi: 10.1016/j.urology.2005.04.003. PMID: 16140062.
  30. Siegel CL, McFarland EG, Brink JA, Fisher AJ, Humphrey P, Heiken JP. CT of cystic renal masses: analysis of diagnostic performance and interobserver variation. AJR Am J Roentgenol. 1997 Sep;169(3):813-8. doi: 10.2214/ajr.169.3.9275902. PMID: 9275902.
  31. Bruner B, Breau RH, Lohse CM, Leibovich BC, Blute ML. Renal nephrometry score is associated with urine leak after partial nephrectomy. BJU Int. 2011 Jul;108(1):67-72. doi: 10.1111/j.1464-410X.2010.09837.x. Epub 2010 Nov 18. PMID: 21087391.
  32. Tobert CM, Kahnoski RJ, Thompson DE, Anema JG, Kuntzman RS, Lane BR. RENAL nephrometry score predicts surgery type independent of individual surgeon's use of nephron-sparing surgery. Urology. 2012 Jul;80(1):157-61. doi: 10.1016/j.urology.2012.03.025. Epub 2012 May 23. PMID: 22626579.
  33. Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol. 2009 Sep;182(3):844-53. doi: 10.1016/j.juro.2009.05.035. Epub 2009 Jul 17. PMID: 19616235.
  34. Johnson CD, Dunnick NR, Cohan RH, Illescas FF. Renal adenocarcinoma: CT staging of 100 tumors. AJR Am J Roentgenol. 1987 Jan;148(1):59-63. doi: 10.2214/ajr.148.1.59. PMID: 3491524.
  35. Studer UE, Scherz S, Scheidegger J, Kraft R, Sonntag R, Ackermann D, Zingg EJ. Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol. 1990 Aug;144(2 Pt 1):243-5. doi: 10.1016/s0022-5347(17)39422-3. PMID: 2374186.
  36. Nayak JG, Patel P, Saarela O, Liu Z, Kapoor A, Finelli A, Tanguay S, Rendon R, Moore R, Black PC, Lacombe L, Breau RH, Kawakami J, Drachenberg DE. Pathological Upstaging of Clinical T1 to Pathological T3a Renal Cell Carcinoma: A Multi-institutional Analysis of Short-term Outcomes. Urology. 2016 Aug;94:154-60. doi: 10.1016/j.urology.2016.03.029. Epub 2016 Mar 31. PMID: 27041471.

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Figure 1

Figure 3

Figure 1

Figure 4

Figure 1

Figure 5

Figure 1

Figure 6

Figure 1

Figure 7

Figure 1

Figure 8

Figure 1

Figure 9

Figure 1

Figure 10

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?